Sign up to save your podcasts
Or
Share Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Gordon Smith talks with Dr. Fredrik Piehl about the use of rituximab for new-onset generalized myasthenia gravis.
Read the related article in JAMA Neurology.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
323 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Clinical Reviews
492 Listeners
The Curbsiders Internal Medicine Podcast
3,318 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,087 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
77 Listeners